1.6 Differential Diagnosis, Indication & Referral Urgency

After history and exposure assessment, Domain 1A asks you to build a differential, state a coherent indication, and judge appropriateness and urgency of referral. These skills are application-heavy on the CGC: candidates must choose what happens next, not only name a syndrome.

Building a genetics-informed differential

A practical differential for congenital or developmental presentations usually includes several buckets:

How to rank the differential

1. Match phenotype to pattern — Is this a known teratogen embryopathy, a classic aneuploidy pattern, or an isolated multifactorial defect?
2. Use timing — Anomaly onset and exposure dates support or weaken buckets.
3. Use base rates and red flags — Multiple major anomalies raise chromosomal/syndromic probability; a single soft marker after reassuring screening may not.
4. Keep more than one bucket open when data are incomplete — CMV and a chromosomal disorder can coexist; diabetes does not exclude trisomy.
5. State what would change management — Differentials should drive tests and referrals, not become endless lists.

Scenario: overlapping buckets

Fetus at 20 weeks with VSD, clenched hands, and growth restriction. Differential includes trisomy 18, other chromosomal imbalance, single-gene syndromes, and less likely isolated multifactorial CHD. If history also shows first-trimester valproate, NTD risk rises for future counseling, but the current phenotype is not explained by valproate alone—urgent prenatal genetic evaluation and diagnostic testing discussion remain appropriate.

Indication: make the "why" explicit

An indication is the clinically justified reason for genetic counseling and/or a specific test. Strong indications are specific:

• "Prenatal counseling for fetal omphalocele and cardiac defect at 18w3d; discuss microarray/karyotype via amniocentesis vs further imaging and screening limitations."
• "Pediatric counseling for developmental delay and congenital anomalies; review CMA and Fragile X as first-tier considerations."
• "Maternal isotretinoin exposure from 4–6 weeks by LMP; teratogen risk counseling and coordinated MFM referral."

Weak indications are vague: "genetic counseling for anxiety," "patient wants all the genes," or "abnormal NIPT" without stating which condition and what confirmatory pathway is needed.

Match indication to test purpose:

• Diagnostic — explain a present phenotype.
• Screening — refine risk in an asymptomatic or low-suspicion setting.
• Carrier — reproductive risk for recessive/X-linked disease.
• Predictive/presymptomatic — future disease risk in an asymptomatic person (needs extra psychosocial and consent rigor).
• Prenatal — fetal risk assessment under gestational time pressure.

Inappropriate indication examples include ordering predictive Huntington testing for a minor without meeting professional guidelines, or using NIPT as a diagnostic test after a high-risk ultrasound without offering diagnostic confirmation counseling.

Appropriateness of referral

Appropriateness means the right clinician, setting, and intensity:

• Genetic counselor visit for risk assessment, education, test selection, and psychosocial support.
• Medical geneticist for complex dysmorphology, management of rare syndromes, or exam-based diagnosis.
• Maternal–fetal medicine for anomalous fetuses, teratogen exposures needing obstetric imaging, and procedure access.
• Specialty clinics (cancer genetics, metabolic, cardiogenetics) when phenotype maps there.
• Emergency/inpatient genetics pathways for neonates with critical congenital anomalies or metabolic crises.

Inappropriate use includes routing every advanced maternal age patient to an urgent same-day invasive procedure without counseling on screening options, or delaying a 12-week high-risk exposure consult until postpartum "when there is more time."

Urgency and time-sensitive windows

Prenatal genetics is paced by the calendar. Urgency escalates when delay will eliminate options or information.

Triage framework for CGC-style items

Ask four questions:

1. Is there an ongoing pregnancy? If yes, gestational age becomes a vital sign for the referral.
2. Will a delay of days/weeks close a testing or decision window?
3. Is the phenotype stable outpatient or critically evolving?
4. Does the family understand options well enough to wait, or do they need same-week counseling to prevent uninformed decisions?

Scenario: urgency done right

A client at 16 weeks has NIPT positive for trisomy 13 and an ultrasound with holoprosencephaly. Appropriate urgency: rapid GC/MFM counseling, discussion of diagnostic confirmation (CVS if still timely vs amniocentesis), and support for time-sensitive decisions. Inappropriate: reassurance that "NIPT is diagnostic, no further testing needed," or scheduling routine counseling in eight weeks.

Scenario: urgency overcalled

A healthy 29-year-old at 9 weeks with no exposures requests counseling solely because a coworker had a child with Down syndrome. Appropriate: offer routine prenatal genetic counseling and screening education. Inappropriate: same-day amniocentesis without indication, or labeling the case as emergent teratogen exposure.

Communication that supports triage

When you refer or accept a referral:

• State the differential top items in plain language.
• Name the indication for today's visit and any recommended test.
• Explain what is urgent and why (window language, not fear language).
• Document follow-up ownership (who calls the lab, who schedules amnio, when results return).
• Avoid dumping undifferentiated "rule out genetic disease" on another service without clinical framing.

Exam traps

• Collapsing differential to a single favorite syndrome despite conflicting exposure history.
• Treating screening results as diagnostic confirmation.
• Missing pregnancy time sensitivity (especially CVS/amnio/NIPT/anatomy follow-up).
• Equating "referral to genetics" with "order the largest panel today."
• Under-triaging neonatal metabolic/critical anomaly cases or over-triaging low-risk anxiety-only consults.
• Forgetting that appropriateness includes psychosocial readiness for predictive testing, not only medical acuity.

Integration across Domain 1A

Clinical information work is a sequence: elicit medical/pregnancy history → classify teratogens and non-genetic risks → synthesize a differential with a clear indication → route with appropriate urgency. Candidates who memorize syndrome lists but cannot triage a 19-week anomalous fetus or a first-trimester isotretinoin exposure will miss Domain 1A application items. Practice saying aloud, for each vignette: What else could this be? What exactly are we evaluating? How soon must we act?